IL245535B - A method for introducing cells from solid tissues - Google Patents

A method for introducing cells from solid tissues

Info

Publication number
IL245535B
IL245535B IL245535A IL24553516A IL245535B IL 245535 B IL245535 B IL 245535B IL 245535 A IL245535 A IL 245535A IL 24553516 A IL24553516 A IL 24553516A IL 245535 B IL245535 B IL 245535B
Authority
IL
Israel
Prior art keywords
solid tissues
introducing cells
introducing
cells
tissues
Prior art date
Application number
IL245535A
Other languages
Hebrew (he)
Other versions
IL245535A0 (en
Original Assignee
Univ North Carolina Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina Chapel Hill filed Critical Univ North Carolina Chapel Hill
Publication of IL245535A0 publication Critical patent/IL245535A0/en
Publication of IL245535B publication Critical patent/IL245535B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/28—Materials or treatment for tissue regeneration for liver reconstruction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/80—Hyaluronan
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2537/00—Supports and/or coatings for cell culture characterised by physical or chemical treatment
    • C12N2537/10—Cross-linking
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Botany (AREA)
IL245535A 2010-05-07 2016-05-08 A method for introducing cells from solid tissues IL245535B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33244110P 2010-05-07 2010-05-07
PCT/US2011/035498 WO2011140428A1 (en) 2010-05-07 2011-05-06 Method of engrafting cells from solid tissues

Publications (2)

Publication Number Publication Date
IL245535A0 IL245535A0 (en) 2016-06-30
IL245535B true IL245535B (en) 2020-09-30

Family

ID=44902076

Family Applications (3)

Application Number Title Priority Date Filing Date
IL222857A IL222857A (en) 2010-05-07 2012-11-05 Use of mixture of liver cells and biomaterials for preparation of a medicament for engraftment in the liver
IL245535A IL245535B (en) 2010-05-07 2016-05-08 A method for introducing cells from solid tissues
IL277184A IL277184A (en) 2010-05-07 2020-09-07 Method of cryopreserving cells

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL222857A IL222857A (en) 2010-05-07 2012-11-05 Use of mixture of liver cells and biomaterials for preparation of a medicament for engraftment in the liver

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL277184A IL277184A (en) 2010-05-07 2020-09-07 Method of cryopreserving cells

Country Status (19)

Country Link
US (1) US20110274666A1 (en)
EP (1) EP2566567A4 (en)
JP (4) JP6177687B2 (en)
KR (4) KR102230864B1 (en)
CN (2) CN111281890A (en)
AR (1) AR081906A1 (en)
AU (1) AU2011247984B2 (en)
BR (1) BR112012028265B1 (en)
CA (2) CA3146949A1 (en)
CL (1) CL2012003085A1 (en)
CR (1) CR20120603A (en)
IL (3) IL222857A (en)
MX (3) MX359678B (en)
NZ (2) NZ630598A (en)
PH (1) PH12012502176A1 (en)
RU (1) RU2736955C2 (en)
SG (2) SG10201503582YA (en)
TW (3) TW202006136A (en)
WO (1) WO2011140428A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013010045A1 (en) 2011-07-12 2013-01-17 Biotime Inc. Novel methods and formulations for orthopedic cell therapy
US8961617B2 (en) * 2012-03-08 2015-02-24 Liventa Bioscience, Inc. Amnion and chorion constructs and uses thereof in abdominal surgery
US9533013B2 (en) 2013-03-13 2017-01-03 University Of North Carolina At Chapel Hill Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree
EP2886644A1 (en) * 2013-12-20 2015-06-24 Kallistem Process for implementing in vitro spermatogenesis and associated device
US10765705B2 (en) 2014-11-24 2020-09-08 Prime Merger Sub, Llc Visco-supplement compositions, and methods of use thereof
WO2016118950A1 (en) * 2015-01-23 2016-07-28 Everon Biosciences, Inc. Induction of cellular senescence for tissue therapies
CN106148266A (en) * 2015-04-20 2016-11-23 烟台赛泽生物技术有限公司 A kind of immunocyte culture medium and the additive of this culture medium
JP2016209303A (en) * 2015-05-08 2016-12-15 レジエンス株式会社 Formulation for reproducing hepatic tissue
US20170369849A1 (en) * 2016-05-11 2017-12-28 The University Of North Carolina At Chapel Hill Compositions and methods for bioengineered tissues
EP3520746A4 (en) 2016-09-30 2020-05-06 Taipei Veterans General Hospital FREEZER PROTECTION AGAINST PROTECTING BIOLOGICAL TISSUE DURING FREEZER TREATMENT AND MANUFACTURING METHOD THEREFOR
JP2020516257A (en) * 2017-04-06 2020-06-11 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｎｏｒｔｈ Ｃａｒｏｌｉｎａ Ａｔ Ｃｈａｐｅｌ Ｈｉｌｌ Cryopreservation method
TW201902467A (en) * 2017-06-12 2019-01-16 北卡羅來納大學教堂山 Patch graft compositions for cell engraftment
CN112334168B (en) 2018-05-03 2024-10-22 科尔普兰特有限公司 Dermal fillers and their uses
JP2020050625A (en) 2018-09-27 2020-04-02 株式会社北里コーポレーション Ovarian tissue transplantation method and follicle activation method
JP7350505B2 (en) * 2019-02-15 2023-09-26 イビデン株式会社 Solidified bodies containing biological samples
JPWO2021060380A1 (en) * 2019-09-27 2021-04-01
WO2023042875A1 (en) * 2021-09-16 2023-03-23 富士フイルム株式会社 Gel formation kit and use thereof
US20250154453A1 (en) * 2021-12-28 2025-05-15 Pormedtec Co., Ltd. Method for producing transplant material, and transplant material
JPWO2024043306A1 (en) * 2022-08-24 2024-02-29
CN116920263A (en) * 2023-07-28 2023-10-24 南方医科大学南方医院 A frozen microneedle for transdermal delivery of living stem cells and its preparation method and application
CN117426368A (en) * 2023-10-08 2024-01-23 北京汇智泰康医药技术有限公司 A kind of hepatocyte cryopreservation solution and its application

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231881B1 (en) * 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
US20040138329A1 (en) * 1992-04-20 2004-07-15 Board Of Regents Of The University Of Texas System Gels for encapsulation of biological materials
WO1994003154A1 (en) * 1992-07-29 1994-02-17 Washington University Use of pouch for implantation of living cells
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5681587A (en) * 1995-10-06 1997-10-28 Desmos, Inc. Growth of adult pancreatic islet cells
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
AU3214797A (en) * 1996-05-28 1998-01-05 Regents Of The University Of Michigan, The Engineering oral tissues
US6224893B1 (en) * 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
JP3014343B2 (en) * 1997-06-06 2000-02-28 科学技術振興事業団 Hepatocyte culture method
IT1293484B1 (en) * 1997-06-11 1999-03-01 Fidia Advanced Biopolymers Srl BIOLOGICAL MATERIAL INCLUDING AN EFFICIENT CELL CULTURE AND A BIOCOMPATIBLE AND BIODEGRADABLE THREE-DIMENSIONAL MATRIX
US6129911A (en) * 1998-07-10 2000-10-10 Rhode Island Hospital, A Lifespan Partner Liver stem cell
DK2048228T3 (en) * 1999-01-19 2016-05-09 Univ North Carolina Human liver progenitors
US6592623B1 (en) * 1999-08-31 2003-07-15 Virginia Commonwealth University Intellectual Property Foundation Engineered muscle
US6365385B1 (en) * 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
ATE288478T1 (en) * 1999-04-30 2005-02-15 Massachusetts Gen Hospital PRODUCTION OF THREE-DIMENSIONAL VASCULARIZED TISSUE USING TWO-DIMENSIONAL MICRO-Fabricated MOLDS
AU6092900A (en) * 1999-07-14 2001-02-05 Board Of Trustees Of The Leland Stanford Junior University Animals comprising human hepatocellular tissue
US6960576B2 (en) 1999-09-13 2005-11-01 Bristol-Myers Squibb Pharma Company Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
RU2165263C1 (en) * 2000-06-23 2001-04-20 Зыбин Дмитрий Владимирович Method of treatment of patients with diabetes mellitus
US7291673B2 (en) * 2000-06-02 2007-11-06 Eidgenossiche Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
US6435190B1 (en) * 2000-06-14 2002-08-20 Syde A. Taheri Autogenous cell patch cardio myoplasty and advanced muscle graft implantation system
MY130475A (en) * 2000-08-25 2007-06-29 Contura As Polyacrylamide hydrogel and its use as an endoprosthesis
US7074424B2 (en) * 2000-11-28 2006-07-11 Genzyme Corporation Polyalkylene glycol viscosity-enhancing polymeric formulations
US20030077566A1 (en) * 2001-09-10 2003-04-24 Palasz Andrzej T. Method for cryopreserving mammalian cells and tissues
WO2004012791A2 (en) * 2002-08-06 2004-02-12 Genvec, Inc. Improved injection system
US7319035B2 (en) * 2002-10-17 2008-01-15 Vbi Technologies, L.L.C. Biological scaffolding material
KR20060032953A (en) * 2003-05-08 2006-04-18 셀라티스 에이비 Cryopreservation of Stem Cells Derived from Human Blastocysts by Use of Closed Straw Vitrification Methods
WO2005021730A2 (en) * 2003-09-02 2005-03-10 University Of North Carolina At Chapel Hill Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells
EP1664282A4 (en) * 2003-09-19 2008-04-09 Newsouth Innovations Pty Ltd Method for isolating hepatocytes
WO2005056763A2 (en) * 2003-12-04 2005-06-23 University Of Utah Research Foundation Process and formulation to improve viability of stored cells and tissue
US7884185B2 (en) * 2004-07-28 2011-02-08 University Of Delaware Hydrogels and uses thereof
US8828433B2 (en) * 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
KR20080097985A (en) * 2005-11-16 2008-11-06 유니버시티 오브 노스캐롤라이나 앳 채플 힐 Extracellular Matrix Components for Enlargement or Differentiation of Liver Precursors
WO2007138119A1 (en) * 2006-05-30 2007-12-06 Instituto Nacional De Investigación Y Tecnología Agraria Y Alimentaria, Inia Procedure for the preparation of unilamellar vesicles for cryopreservation and the culture of stem cells and embryos
TW200817019A (en) * 2006-07-10 2008-04-16 Univ Columbia De novo formation and regeneration of vascularized tissue from tissue progenitor cells and vascular progenitor cells
US8084055B2 (en) * 2006-09-21 2011-12-27 Purdue Research Foundation Collagen preparation and method of isolation
US20080233088A1 (en) * 2007-02-16 2008-09-25 Varian Medical Systems Technologies, Inc. Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo after transplantation
BRPI0808696A2 (en) * 2007-03-06 2015-06-23 Univ North Carolina Hyuronan complexes, other matrix components, hormones and growth factors for cell maintenance, expansion and / or differentiation
US20080312581A1 (en) * 2007-06-06 2008-12-18 Biovaluation & Analysis, Inc. Peptosomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
JP2010529855A (en) * 2007-06-15 2010-09-02 ユニバーシティ オブ ノース カロライナ アット チャペル ヒル Paracrine signals derived from mesenchymal feeder cells and the use of them to regulate the increase and differentiation of hepatic progenitors
GB0713079D0 (en) * 2007-07-05 2007-08-15 Ucl Business Plc biomaterial scaffolds with defined stiffness
US8242076B2 (en) * 2007-08-15 2012-08-14 Ramot At Tel-Aviv University Ltd. Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair
US20110178182A1 (en) * 2007-08-20 2011-07-21 Do-Coop Technologies Ltd. Enriched nanostructure composition
EP3338549A1 (en) * 2007-11-20 2018-06-27 Pioneer Surgical Orthobiologics, Inc. Cryopreservation of cells using cross-linked bioactive hydrogel matrix particles
CN101618235A (en) * 2008-07-01 2010-01-06 中国人民解放军军事医学科学院基础医学研究所 Injectable myocardial tissue engineering product applying OPF-based hydrogel as liquid scaffold
US9216188B2 (en) * 2008-09-04 2015-12-22 The General Hospital Corporation Hydrogels for vocal cord and soft tissue augmentation and repair
US20100092533A1 (en) * 2008-10-15 2010-04-15 Joshua Stopek Bioabsorbable Surgical Composition
EP2221362A1 (en) * 2009-02-19 2010-08-25 Naturin GmbH & Co Method for the cryopreservation of cells, artificial cell constructs or three-dimensional complex tissues assemblies

Also Published As

Publication number Publication date
PH12012502176A1 (en) 2013-02-04
US20110274666A1 (en) 2011-11-10
RU2015155133A (en) 2019-01-16
TW201823452A (en) 2018-07-01
JP6891010B2 (en) 2021-06-18
KR20210100748A (en) 2021-08-17
JP2022022305A (en) 2022-02-03
TW202006136A (en) 2020-02-01
IL222857A0 (en) 2012-12-31
CN111281890A (en) 2020-06-16
EP2566567A1 (en) 2013-03-13
RU2015155133A3 (en) 2019-05-28
TWI687518B (en) 2020-03-11
RU2736955C2 (en) 2020-11-23
KR20190012279A (en) 2019-02-08
MX2012012836A (en) 2013-04-03
AR081906A1 (en) 2012-10-31
SG185425A1 (en) 2012-12-28
MX2019009549A (en) 2019-10-02
CA2798458C (en) 2022-04-19
CN102985130A (en) 2013-03-20
KR20130108996A (en) 2013-10-07
KR102230864B1 (en) 2021-03-23
WO2011140428A1 (en) 2011-11-10
JP7358441B2 (en) 2023-10-10
CA2798458A1 (en) 2011-11-10
CA3146949A1 (en) 2011-11-10
IL222857A (en) 2016-05-31
IL245535A0 (en) 2016-06-30
BR112012028265A2 (en) 2016-11-01
TW201202424A (en) 2012-01-16
JP6177687B2 (en) 2017-08-09
IL277184A (en) 2020-10-29
SG10201503582YA (en) 2015-06-29
BR112012028265B1 (en) 2021-09-21
NZ630598A (en) 2016-02-26
AU2011247984B2 (en) 2015-04-30
NZ603913A (en) 2015-09-25
JP2019178155A (en) 2019-10-17
KR20190128754A (en) 2019-11-18
JP2017131682A (en) 2017-08-03
MX2020002474A (en) 2020-07-20
AU2011247984A1 (en) 2013-01-10
MX359678B (en) 2018-10-05
RU2012152610A (en) 2014-06-20
JP2013526297A (en) 2013-06-24
EP2566567A4 (en) 2014-11-26
CL2012003085A1 (en) 2014-01-10
CR20120603A (en) 2013-05-15
JP6987811B2 (en) 2022-01-05
KR102493613B1 (en) 2023-01-31
KR102289168B1 (en) 2021-08-11

Similar Documents

Publication Publication Date Title
IL245535B (en) A method for introducing cells from solid tissues
IL225536B (en) A method for activating a t-helper cell
BR112012015988A2 (en) method
EP2556482A4 (en) Automated story generation
BR112012004707A2 (en) method
BR112012000624A2 (en) method
BRPI1012526A2 (en) method
FI20105640A7 (en) Method for preparing microcellulose
BRPI1010705A2 (en) method
GB201104967D0 (en) Hyper-spatial methods for modeling biological events
SG10201509096SA (en) Methods for organ regeneration
BR112013011848A2 (en) improved connection method
IL227121A (en) A method for freezing cells
BR112013009024A2 (en) method
BR112012023891A2 (en) method
IL222479A (en) Methods for tissue engineering
BRPI1009350A2 (en) method
GB201006768D0 (en) Method for obtaining dendritic cells
BR112013015580A2 (en) radiostabilization method
BR112012033000A2 (en) method
EP2612745A4 (en) STRATIFICATION METHOD
FI20100034L (en) Method for storing filtrate
AP3548A (en) Method for fractionating jatropha seeds
GB2485887B (en) Improved anode for concrete
GB201105366D0 (en) Method for analysing sward

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed